CASE REPORT article
Front. Cardiovasc. Med.
Sec. Cardiovascular Genetics and Systems Medicine
Case report: De Novo USP9X Missense Mutation in a Male Fetus with Pulmonary Atresia and Ventricular Septal Defect: Expanding the Genotype-Phenotype Spectrum of USP9X-Related Disorders
Tingting Man 1,2
Hairui Sun 1,2
Xiaoyan Hao 1,2
Xiaowei Liu 1,2
YIhua He 1,2,3
1. Maternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
2. Beijing Lab for cardiovascular Precision Medicine, Capital Medical University, Beijing, China
3. Laboratory for Clinical Medicine, Capital Medical University, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Background: Pathogenic variants in the X-linked USP9X gene, which evades X-chromosome inactivation, have been predominantly linked to neurodevelopmental disorders (NDDs). Accumulating evidence has linked USP9X dysfunction to congenital heart disease (CHD), yet the specific genotype-phenotype correlations in this context remain poorly characterized. Pulmonary atresia with ventricular septal defect (PA/VSD) represents a severe and complex form of congenital heart disease (CHD), characterized by heterogeneous etiological mechanisms. Case Presentation: A 34-year-old G2P1L1 woman was referred at 22 weeks of gestation for prenatal echocardiography due to suspected fetal cardiac anomaly. Echocardiographic evaluation identified a male fetus with PA/VSD. Following detailed counseling, the couple elected to terminate the pregnancy due to the poor prognosis and opted for subsequent genetic testing. Trio whole-exome sequencing (WES) identified a de novo hemizygous missense variant in USP9X (NM_001039590.3: c.5186A>G; p.His1729Arg; rs2147230302) in the male fetus. This variant is categorized as "Likely Pathogenic" in ClinVar for female-restricted syndromic neurodevelopmental disorders (NDDs), yet it has not been previously linked to congenital heart diseases (CHDs), specifically PA/VSD. The p.His1729Arg substitution impacts a conserved residue within the structurally critical zinc-finger domain of the USP9X protein. Comprehensive genetic screening failed to identify additional pathogenic variants that could explain the observed phenotype. Conclusion: This case represents the first report establishing a link between the de novo p.His1729Arg variant in USP9X and the CHD phenotype of PA/VSD in a male fetus. This finding broadens the known phenotypic spectrum of this likely pathogenic USP9X variant, underscoring its pleiotropic effects and implicating the gene in critical cardiac developmental pathways. Routine cardiac assessment is recommended for individuals harboring pathogenic USP9X variants.
Summary
Keywords
Congenital heartdisease, genotype-phenotype correlation, Pulmonary atresia with ventricular septal defect, Usp9x, Whole-exome sequencing
Received
16 October 2025
Accepted
16 February 2026
Copyright
© 2026 Man, Sun, Hao, Liu and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: YIhua He
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.